Bipolar Disorder Treatment: Current Standards and Outlook
Bipolar disorder requires long-term, multimodal management. No FDA-approved single-injection or "shot" provides sustained treatment.
Pharmacotherapy (Cornerstone)
- Mood stabilizers: Lithium (gold standard), valproate, carbamazepine, lamotrigine (depression prophylaxis).
- Atypical antipsychotics: Quetiapine, lurasidone, cariprazine, olanzapine, aripiprazole — acute mania/mixed, maintenance, bipolar depression.
- Antidepressants: Cautious, adjunctive with mood stabilizer (risk of switch).
- Long-acting injectables (LAIs): Aripiprazole, risperidone, paliperidone — for adherence, not monotherapy cure.
Psychotherapy
- CBT, IPSRT (interpersonal social rhythm), FFT (family-focused), psychoeducation — improve adherence, episode recognition, circadian stability.
Lifestyle
- Regular sleep/wake cycles (critical).
- Exercise, stress management, substance avoidance.
- Mood charting.
Emerging/Experimental
- Ketamine/esketamine (acute bipolar depression).
- Neuromodulation (TMS, DBS — research).
- Novel targets (mitochondrial, inflammatory, circadian).
Prognosis
Chronic, relapsing-remitting. With adherence, many achieve functional recovery. Ongoing psychiatrist care is standard.
Bipolar Disorder - Related Articles
- Natural Approaches to Managing Bipolar Disorder: Complementary Therapies
- Bipolar Disorder Treatment: Medication & Therapy Options
- Understanding Medication Management for Bipolar Disorder
- Understanding and Supporting Individuals with Bipolar Disorder
- Hypersensitivity Reaction Duration by Type: What to Expect & When to Act
- Understanding Bipolar I Disorder: Pathophysiology and Key Features
- Bipolar Disorder Treatment: Holistic & European Approaches